This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Nov. 27, 2013


 



Low-intensity therapy for Burkitt lymphoma is highly effective
Oncology Nurse Advisor
Adult patients with Burkitt lymphoma had excellent long-term survival rates — upwards of 90 percent — following treatment with low-intensity chemotherapy regimens, according to a new clinical trial finding. Standard treatment for Burkitt lymphoma involves high-dose chemotherapy, which has a high rate of toxicity, including death, and a cure rate of only 60 percent in adult patients.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Cervical cancer screening overused in some groups of women
Medical Xpress
For the past 10 years, clinicians throughout the United States have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women, according to a researcher from Huntsman Cancer Institute (HCI) at the University of Utah. The research results were published online in the Journal of the American Medical Association Internal Medicine. Because the risk of developing this slow-growing cancer is very small at such a late stage in life, Pap tests do not benefit women over age 65 who have no history of cervical cancer or precancerous conditions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


AJCC-NCRA Education Needs Assessment Survey
AJCC
Beginning with cases diagnosed Jan. 1, 2016, and after, the standard-setters in the U.S. and Canada will require AJCC TNM and Summary Stage coding to be recorded in the cancer registry abstract. Collaborative Stage will no longer be used. To ensure the cancer surveillance community is prepared for this change, the AJCC has asked NCRA to prepare an Education Needs Assessment. The goal of the assessment is to identify gaps in knowledge and skills in order to determine the training and education needed to prepare for the 2016 shift in staging process.

Your help is needed to assure that your education/training needs are understood and can be met! Please complete this survey to help and in the process earn 1 complimentary CE.

The survey will take 45-60 minutes and needs to be completed in one sitting. Once you finish and submit the survey, NCRA will follow-up with details on how to obtain your CE completion certificate.

There are two surveys and you should take the one that best relates to your primary work. If your primary work is in, or for, a Hospital Registry, http://www.sogosurvey.com/k/RQsQTYPPsVsPsPsP. If your primary work is in, or for, a Central, Regional, Provincial or Federal Registry, http://www.sogosurvey.com/k/RQsQTYPPsUsPsPsP. These surveys will close on Dec. 10. Thank you for your help!

Questions? E-mail cirvin@ncra-usa.org

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Team finds potential cause for deadly breast cancer relapse
Medical Xpress
Researchers at the University of North Carolina School of Medicine (UNC), working with cell lines in a lab, have discovered why some of the most aggressive and fatal breast cancer cells are resistant to chemotherapy, and UNC scientists are developing ways to overcome such resistance. Adriana S. Beltran, PhD, a research assistant professor in the department of pharmacology, found that the protein Engrailed 1 is overexpressed in basal-like carcinomas and designed a chain of amino acids to shut down the protein and kill basal-like tumors in the lab.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Special Offer for Readers of The CoC Brief — Practice Review
Are you concerned about diminishing reimbursements? Time to take action and give your practice a check up!
1) Take advantage of the complimentary Practice Analysis.
2) See how you can prepare for the Affordable care Act.
From production and reimbursement to coding and A/R, find out where you are and what you can do to take advantage of the changes in healthcare and to protect your practice.
 


Oral cancer screenings by primary care physician recommendations updated
dailyRX
Because tobacco use has been declining in the U.S. over recent years, cancers found in the mouth have also been on the decline. The U.S. Preventive Services Task Force (USPSTF) has updated its 2004 recommendation on primary care physicians screening for oral cancers. The task force did not find enough evidence to recommend for or against oral cancer screenings by primary care physicians in adults with no symptoms of the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Marker predicts radiation failure in nasopharyngeal cancer
Medscape
A cytokine found in the blood of patients with nasopharyngeal carcinoma (NPC) can lead to a strategy for sensitizing some radiotherapy-resistant tumors, according to a study published online Nov. 25 in the Journal of Clinical Investigation. Shu-Chen Liu, PhD, associate professor at the Molecular Medicine Research Center at Chang Gung University, Taoyuan, Taiwan, and colleagues found increased serum levels of leukemia inhibitory factor (LIF) in patients with local tumor recurrence after radiotherapy for Epstein-Barr virus (EBV)-associated NPC.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


National Cancer Data Base (NCDB) Call for Data
CoC Source
The official NCDB Call for Data announcement was sent to all programs in a special CoC Source on Oct. 15. The submission edits for the upcoming Call for Data will be posted at the beginning of December. Do not select cases for NCDB submission until at least Dec. 1 to avoid missing any cases. In the meantime, pre edit using the NAACCR edit set for "Hospitals - All," which should be available in your software (you may have to ask your software provider what it is called there). That is the same edit set that must be used in order to stamp your cases "Date Case Complete - CoC" and is the source for most NCDB submission edits.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Advertisement
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
Advertisement
Cancer Registry Impact

Ensure the highest quality oncology data reporting to help improve care and aid in decision making. Learn about Care Communications, Inc. Cancer Registry Services.


Integrating CAM therapies into oncology care
Oncology Nurse Advisor
Patients with cancer often raise questions about how they might use integrative therapies, complementary therapies, and alternative treatments. Oncology nurses should be knowledgeable about these areas so they can discuss them with patients and answer their patients' questions. An estimated 10 percent to more than 60 percent of oncology patients use other therapies in addition to their prescribed treatment. Skillfully discussing these approaches allows patients to freely discuss all choices in their care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Chemotherapy: When intestinal bacteria provide reinforcement
Science Codex
Researchers have just shown that the efficacy of one of the molecules most often used in chemotherapy relies to an extent on its capacity to mobilize certain bacteria from the intestinal flora toward the bloodstream and lymph nodes. Once inside the lymph nodes, these bacteria stimulate fresh immune defenses, which then enhance the body's ability to fight the malignant tumor. Results of this work were published in the journal Science on Nov. 22.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Accreditation 101: Learning the Basics of CoC Accreditation and Standards
Commission on Cancer
Are you a new staff member just learning the ropes of CoC accreditation?
Is your cancer program considering CoC accreditation and you want to learn about the CoC standards?
Do you need a basic refresher on the CoC accreditation process and standards?

If you answered yes to any of these questions, then plan to attend Accreditation 101: Learning the Basics of CoC Accreditation and Standards in Austin, Texas, on Feb. 28, 2014. This is the only program developed and taught by CoC surveyors and staff who review the CoC Standards, provide practical information on how to achieve compliance, and discuss the important role you and your cancer team play throughout the continuum of cancer care. Get the information you need from the people involved in standard development and the survey process. For additional information, go to www.facs.org/cancer.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Sweet drinks linked to endometrial cancer risk after menopause
Medical News Today
Women who consume sugary drinks regularly have a higher risk of developing estrogen-dependent type I endometrial cancer after the menopause compared with other women of the same age, according to a study carried out at the University of Minnesota and published in Cancer Epidemiology, Biomarkers & Prevention. The National Cancer Institute in the United States reports that there are about 49,560 new cases of endometrial cancer and 8,190 deaths caused by the disease annually. Most women develop endometrial cancer after 55 years of age.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword ENDOMETRIAL CANCER.
 
Advertisement

Advertisement

Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Nov. 20, 2013
Nov. 13, 2013
Nov. 6, 2013
Oct. 30, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063